Carbon copies? Authors retract paper from leading chemistry journal

jacsat_v135i031.inddThe authors of a 2008 Journal of the American Chemical Society (JACS) paper have retracted it after a structure was “mistakenly assigned.”

The article, “Highly Enantioselective Radical Addition to N-Benzoyl Hydrazones Using Chiral Ammonium Salts,” was written by Doo Ok Jang and Sang Yoon Kim, chemists at Yonsei University, in Wonju. According to the abstract (which includes this molecular schema):

Continue reading Carbon copies? Authors retract paper from leading chemistry journal

Virtual reality researcher notches fifth retraction

techforcchangeA researcher who studies the use of virtual reality and other media and who has already had four retractions has retracted another paper.

The 2007 paper by Dong Hee Shin, then of Penn State University, appeared in Technological Forecasting and Social Change and was titled “Potential user factors driving adoption of IPTV. What are customers expecting from IPTV?” It has been cited 24 times, according to Thomson Scientific’s Web of Knowledge.

According to the notice: Continue reading Virtual reality researcher notches fifth retraction

Paper by NASA scientists retracted for plagiarizing NASA report

레이아웃 1A team of researchers including NASA scientists have retracted a December 2012 article because it plagiarized…a 2000 NASA report.

Here’s the notice for “A Fosmid Cloning Strategy for Detecting the Widest Possible Spectrum of Microbes from the International Space Station Drinking Water System,” published in Genomics & Informatics: Continue reading Paper by NASA scientists retracted for plagiarizing NASA report

“Clear case of plagiarism” forces retraction of chemistry paper

jrnlchemscieThe Journal of Chemical Sciences,  the journal of the Indian Academy of Sciences, has retracted a 2012 paper by a group of researchers in India and South Korea who stole material (and a lot of it) from a 2009 article for their reactant.

The retraction notice (it’s a pdf) speaks quite well for itself:

Continue reading “Clear case of plagiarism” forces retraction of chemistry paper

Double submission leads to retraction of probability paper — and a publishing ban

jtbWhat are the chances of successfully duplicating publication in the Journal of Theoretical Probability? Not too high, it seems.

A pair of South Korean authors have gotten a five-year ban from the journal for double-publishing a paper in the math literature.

The article, “Convergence of Weighted Sums for Arrays of Negatively Dependent Random Variables and Its Applications,” was written by Jong-Il Baek and Sung-Tae Park of Wonkwang University in IkSan.

According to the retraction notice: Continue reading Double submission leads to retraction of probability paper — and a publishing ban

Four papers about gaming and virtual worlds become more virtual and less reality as they’re retracted

int j human-computer interactionThe International Journal of Human-Computer Interaction has retracted four papers about virtual reality for reasons that aren’t quite clear.

The common author of the studies is Dong-Hee Shin of Seoul’s Sungkyunkwan University. Here’s the retraction notice, which is signed by journal editors-in-chief Gavriel Salvendy and Julie Jacko: Continue reading Four papers about gaming and virtual worlds become more virtual and less reality as they’re retracted

Updated: Integrity “uncertain,” journal retracts stroke paper

emmcover

Experimental & Molecular Medicine has retracted a 2012 paper on stroke by a group of South Korean researchers after learning that one of the figures in the article was unreliable.

The article was titled “Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury,” and it came from a team at Hallym University in Chunchon.

According to the retraction notice: Continue reading Updated: Integrity “uncertain,” journal retracts stroke paper

Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper

cell cloningCell is looking into whether the authors of a widely hailed study published last week claiming to have turned human skin cells into embryonic stem cells manipulated images inappropriately, Retraction Watch has learned.

The potential image problems came to light on PubPeer, a site designed to allow for post-publication peer review. A commenter, identified as Peer1, identified “several examples of image reuse which might be of interest to PubPeer members and readers:” Continue reading Cell reviewing allegations of image reuse in human embryonic stem cell cloning paper

RNA paper retracted for “carelessness in including some of the figures”

molcellbiochemHere at Retraction Watch, we’ve covered retractions for misconduct, journal errors, editorial system hacking and even no particular reason.

And that’s just in the last week.

However, we’ve identified a new reported reason: carelessness. A paper in Molecular and Cellular Biochemistry claimed to show how a tiny RNA causes fat cells to die.

Instead, the paper died.

Turned out that rather than describe previously published data, the authors say they inadvertently included a figure that had already appeared in another paper.

The retraction for “miR-598 induces replicative senescence in human adipose tissue-derived mesenchymal stem cells via silent information regulator 1,” reads, in full: Continue reading RNA paper retracted for “carelessness in including some of the figures”

Loose lips sink paper on company’s experimental pain drug

A bit of intellectual property indiscretion has led to the retraction of a paper by Korean scientists. Although the details are fuzzy, several of the authors are affiliated with a Korean pharma company called SK.

The paper, “A Novel Carbamoyloxy Arylalkanoyl Arylpiperazine Compound (SKL-NP) Inhibits Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Currents in Rat Dorsal Root Ganglion Neurons,” was published in the The Korean Journal of Physiology & Pharmacology earlier this year.

According to the retraction notice: Continue reading Loose lips sink paper on company’s experimental pain drug